New Perspectives on the Treatment of Multiple Myeloma in the Relapse Setting: Case Discussion and Common Clinical Scenarios

In this program experts describe considerations and therapeutic strategies for myeloma in the early relapse setting and in heavily pretreated disease and discuss emerging novel therapies.

Share

Program Content

Activities

Relapsed MM Advances
Managing Multiple Myeloma in the Relapsed Setting: Expert Perspectives on Recent Advances
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 02, 2022

Expires: November 01, 2023

Activities

RR MM Therapies
New Perspectives on the Treatment of Multiple Myeloma In The Relapse Setting: Case Discussion and Common Clinical Scenarios
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 06, 2022

Expires: October 05, 2023

Activities

RRMM New Perspectives
New Perspectives on the Treatment of Multiple Myeloma in the Relapse Setting: Case Discussion and Common Clinical Scenarios
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2022

Expires: November 14, 2023

Faculty

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Janssen administered by Scientific Affairs

Karyopharm Therapeutics